Literature DB >> 19720047

MicroRNA-133 regulates the expression of GLUT4 by targeting KLF15 and is involved in metabolic control in cardiac myocytes.

Takahiro Horie1, Koh Ono, Hitoo Nishi, Yoshitaka Iwanaga, Kazuya Nagao, Minako Kinoshita, Yasuhide Kuwabara, Rieko Takanabe, Koji Hasegawa, Toru Kita, Takeshi Kimura.   

Abstract

GLUT4 shows decreased levels in failing human adult hearts. We speculated that GLUT4 expression in cardiac muscle may be fine-tuned by microRNAs. Forced expression of miR-133 decreased GLUT4 expression and reduced insulin-mediated glucose uptake in cardiomyocytes. A computational miRNA target prediction algorithm showed that KLF15 is one of the targets of miR-133. It was confirmed that over-expression of miR-133 reduced the protein level of KLF15, which reduced the level of the downstream target GLUT4. Cardiac myocytes infected with lenti-decoy, in which the 3'UTR with tandem sequences complementary to miR-133 was linked to the luciferase reporter gene, had decreased miR-133 levels and increased levels of GLUT4. The expression levels of KLF15 and GLUT4 were decreased at the left ventricular hypertrophy and congestive heart failure stage in a rat model. The present results indicated that miR-133 regulates the expression of GLUT4 by targeting KLF15 and is involved in metabolic control in cardiomyocytes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19720047     DOI: 10.1016/j.bbrc.2009.08.136

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  76 in total

Review 1.  MicroRNA sponges: progress and possibilities.

Authors:  Margaret S Ebert; Phillip A Sharp
Journal:  RNA       Date:  2010-09-20       Impact factor: 4.942

Review 2.  microRNAs in heart disease: putative novel therapeutic targets?

Authors:  Gianluigi Condorelli; Michael V G Latronico; Gerald W Dorn
Journal:  Eur Heart J       Date:  2010-01-29       Impact factor: 29.983

Review 3.  In vivo delivery of miRNAs for cancer therapy: challenges and strategies.

Authors:  Yunching Chen; Dong-Yu Gao; Leaf Huang
Journal:  Adv Drug Deliv Rev       Date:  2014-05-22       Impact factor: 15.470

4.  Catabolic Defect of Branched-Chain Amino Acids Promotes Heart Failure.

Authors:  Haipeng Sun; Kristine C Olson; Chen Gao; Domenick A Prosdocimo; Meiyi Zhou; Zhihua Wang; Darwin Jeyaraj; Ji-Youn Youn; Shuxun Ren; Yunxia Liu; Christoph D Rau; Svati Shah; Olga Ilkayeva; Wen-Jun Gui; Noelle S William; R Max Wynn; Christopher B Newgard; Hua Cai; Xinshu Xiao; David T Chuang; Paul Christian Schulze; Christopher Lynch; Mukesh K Jain; Yibin Wang
Journal:  Circulation       Date:  2016-04-08       Impact factor: 29.690

Review 5.  Mechanisms and therapeutic potential of microRNAs in hypertension.

Authors:  Lijun Shi; Jingwen Liao; Bailin Liu; Fanxing Zeng; Lubo Zhang
Journal:  Drug Discov Today       Date:  2015-05-21       Impact factor: 7.851

6.  Ergot alkaloid exposure during gestation alters: 3. Fetal growth, muscle fiber development, and miRNA transcriptome1.

Authors:  Maslyn A Greene; Jessica L Britt; Rhonda R Powell; F Alex Feltus; William C Bridges; Terri Bruce; James L Klotz; Markus F Miller; Susan K Duckett
Journal:  J Anim Sci       Date:  2019-07-02       Impact factor: 3.159

Review 7.  MicroRNA regulation and analytical methods in cancer cell metabolism.

Authors:  Ling-Fei Zhang; Shuai Jiang; Mo-Fang Liu
Journal:  Cell Mol Life Sci       Date:  2017-03-20       Impact factor: 9.261

8.  Lack of miR-133a Decreases Contractility of Diabetic Hearts: A Role for Novel Cross Talk Between Tyrosine Aminotransferase and Tyrosine Hydroxylase.

Authors:  Shyam Sundar Nandi; Hong Zheng; Neeru M Sharma; Hamid R Shahshahan; Kaushik P Patel; Paras K Mishra
Journal:  Diabetes       Date:  2016-07-13       Impact factor: 9.461

Review 9.  Non-coding RNAs: the new central dogma of cancer biology.

Authors:  Phei Er Saw; Xiaoding Xu; Jianing Chen; Er-Wei Song
Journal:  Sci China Life Sci       Date:  2020-09-11       Impact factor: 6.038

Review 10.  Roles of the canonical myomiRs miR-1, -133 and -206 in cell development and disease.

Authors:  Keith Richard Mitchelson; Wen-Yan Qin
Journal:  World J Biol Chem       Date:  2015-08-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.